Wired: Bad results from drug trials no longer have a place to hide In 2007, US Food and Drugs Administration (FDA) Amendments Act was passed. The law laid out many different ways to try and improve the way new drugs are developed, including a publicly-available database of all clinical trials and a rule that certain clinical trial results must be reported within 12 months of the trial being completed. Until the 'final rule' was published last year, for trials finishing on the 17th January 2017, the FDA was not able to issue fines. But now, since the trials ending in January have been given their 30-day grace period, fines can start to mount up; fines of up to up to $10,000 a day. This is where Trials Tracker comes in. Dr Goldacre worked on the tool with colleagues on the Alltrials campaign and at the University of Oxford's Evidence-Based Medicine DataLab. The team developed a tool to take data from the website ClinicalTrials.gov, where all clinical trials data is publicly available. It shows exactly which trials are overdue, what they were about and how much the FDA could claim in fines.